Hsian-Rong Tseng
Affiliations: | Biomedical Engineering 0289 | University of California, Los Angeles, Los Angeles, CA |
Area:
Biomedical Engineering, NanotechnologyGoogle:
"Hsian-Rong Tseng"Parents
Sign in to add mentor| Tien-Yau Luh | grad student | 1994-1998 | National Taiwan University (Chemistry Tree) |
Children
Sign in to add trainee| Tak F. Yu | grad student | 2009 | UCLA |
| Kuan-Ju Chen | grad student | 2012 | UCLA |
| Mitch André Garcia | post-doc | 2010-2013 | UCLA (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Court CM, Hou S, Liu L, et al. (2020) Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells. Npj Precision Oncology. 4: 16 |
| Wang J, Sun N, Lee YT, et al. (2020) A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer. Journal of Materials Chemistry. B |
| Ahn JC, Teng PC, Chen PJ, et al. (2020) Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (Baltimore, Md.) |
| Teng P, Jan YJ, Chen J, et al. (2020) Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy. Journal of Clinical Oncology. 38: 170-170 |
| Wang JJ, Teng P, Jan YJ, et al. (2020) Association of very small nuclear circulating tumor cell (vsnCTC) with clinical outcomes in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 38: 168-168 |
| Wang JJ, Teng P, Jan YJ, et al. (2020) Circulating tumor cells with small nuclear size: A novel biomarker for survival and clinical outcomes in advanced prostate cancer. Journal of Clinical Oncology. 38 |
| Teng P, Jan YJ, Kim M, et al. (2020) Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. Journal of Clinical Oncology. 38 |
| Wang JJ, Teng P, Jan YJ, et al. (2020) Abstract 4331: Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer Endocrinology |
| Dong J, Chen J, Smalley M, et al. (2020) Circulating Rare Cells: Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications (Adv. Mater. 1/2020) Advanced Materials. 32: 2070008 |
| Dong J, Chen JF, Smalley M, et al. (2019) Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Advanced Materials (Deerfield Beach, Fla.). e1903663 |